FRANKFURT -(Dow Jones)- French pharmaceutical company Sanofi-Aventis (SNY) (SNY) Friday specified it will inject up to EUR51 million for the expansion of its Frankfurt production site. On Thursday, Matthias Braun, head of active ingredients production in Frankfurt, had told Dow Jones Newswires the investment could total EUR42 million.
